| ID | 117233 |
| Author |
Bando, Hiroshi
Kanaiso Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association
KAKEN Search Researchers
Yamashita, Hisako
Kanaiso Hospital
Kato, Yoshinobu
Kanaiso Hospital
Ogura, Katsunori
Kanaiso Hospital
Kato, Yoshikane
Kanaiso Hospital
Kanazawa, Setsuko
Kanaiso Hospital
|
| Keywords | Type 2 diabetes
Obesity
Oral semaglutide
Weight
|
| Content Type |
Journal Article
|
| Description | Background: Obesity and Type 2 Diabetes (T2D) are crucial problems worldwide. Oral semaglutide (Rybelsus) was introduced to medical practice for Glucagon-Like Peptide 1 Receptor Agonist (GLP-1RA). Case presentation: The patient is 24-year-old female with obesity (BMI 39.3 kg/m2), T2D and fatty liver. Results: She started and increased Rybelsus from 3mg, 7mg to 14mg/day each 4 weeks. She showed significant efficacy for 4 months as HbA1c 6.3% to 5.6% and weight 107kg to 103kg, without Gastrointestinal Adverse Events (GIAEs). Discussion: Rybelsus is provided just after waking up, and kept >30 min fasting period. Longer fasting time may contribute current effect.
|
| Journal Title |
Journal of Obesity and Diabetes
|
| ISSN | 2638812X
|
| Publisher | Edelweiss Publications
|
| Volume | 5
|
| Issue | 1
|
| Start Page | 11
|
| End Page | 14
|
| Published Date | 2022-06-22
|
| Rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| DOI (Published Version) | |
| URL ( Publisher's Version ) | |
| FullText File | |
| language |
eng
|
| TextVersion |
Publisher
|
| departments |
Medical Sciences
|
